BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 1469637)

  • 1. Whole body and brain distribution of [3H]cyclic [D-Pen2,D-Pen5] enkephalin after intraperitoneal, intravenous, oral and subcutaneous administration.
    Weber SJ; Greene DL; Hruby VJ; Yamamura HI; Porreca F; Davis TP
    J Pharmacol Exp Ther; 1992 Dec; 263(3):1308-16. PubMed ID: 1469637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution and analgesia of [3H][D-Pen2, D-Pen5]enkephalin and two halogenated analogs after intravenous administration.
    Weber SJ; Greene DL; Sharma SD; Yamamura HI; Kramer TH; Burks TF; Hruby VJ; Hersh LB; Davis TP
    J Pharmacol Exp Ther; 1991 Dec; 259(3):1109-17. PubMed ID: 1762065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [D-Pen2,4'-125I-Phe4,D-Pen5]enkephalin: a selective high affinity radioligand for delta opioid receptors with exceptional specific activity.
    Knapp RJ; Sharma SD; Toth G; Duong MT; Fang L; Bogert CL; Weber SJ; Hunt M; Davis TP; Wamsley JK
    J Pharmacol Exp Ther; 1991 Sep; 258(3):1077-83. PubMed ID: 1653834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opioid modulation of basal intestinal fluid transport in the mouse: actions at central, but not intestinal, sites.
    Jiang Q; Sheldon RJ; Porreca F
    J Pharmacol Exp Ther; 1990 May; 253(2):784-90. PubMed ID: 2160010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of mu and delta receptors in the supraspinal and spinal analgesic effects of [D-Pen2, D-Pen5]enkephalin in the mouse.
    Porreca F; Heyman JS; Mosberg HI; Omnaas JR; Vaught JL
    J Pharmacol Exp Ther; 1987 May; 241(2):393-400. PubMed ID: 3033214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential antagonism of opioid delta antinociception by [D-Ala2,Leu5,Cys6]enkephalin and naltrindole 5'-isothiocyanate: evidence for delta receptor subtypes.
    Jiang Q; Takemori AE; Sultana M; Portoghese PS; Bowen WD; Mosberg HI; Porreca F
    J Pharmacol Exp Ther; 1991 Jun; 257(3):1069-75. PubMed ID: 1646319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of intracerebroventricular beta-funaltrexamine on mu opioid receptors in the rat brain: consideration of binding condition.
    Liu-Chen LY; Yang HH; Li S; Adams JU
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1047-56. PubMed ID: 7791074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postnatal development of delta-opioid receptor subtypes in mice.
    Negri L; Severini C; Lattanzi R; Potenza RL; Melchiorri P
    Br J Pharmacol; 1997 Mar; 120(6):989-94. PubMed ID: 9134207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood-brain disposition and antinociceptive effects of -D-penicillamine2,5-enkephalin in the mouse.
    Chen C; Pollack GM
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1151-9. PubMed ID: 9399988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioid agonist and antagonist antinociceptive properties of [D-Ala2,Leu5,Cys6]enkephalin: selective actions at the deltanoncomplexed site.
    Qi JA; Bowen WD; Mosberg HI; Rothman RB; Porreca F
    J Pharmacol Exp Ther; 1990 Nov; 255(2):636-41. PubMed ID: 2173752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of antinociceptive cross-tolerance between [D-Pen2, D-Pen5]enkephalin and [D-Ala2]deltorphin II in mice: evidence for delta receptor subtypes.
    Mattia A; Vanderah T; Mosberg HI; Porreca F
    J Pharmacol Exp Ther; 1991 Aug; 258(2):583-7. PubMed ID: 1650835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissociation of opioid antinociception and central gastrointestinal propulsion in the mouse: studies with naloxonazine.
    Heyman JS; Williams CL; Burks TF; Mosberg HI; Porreca F
    J Pharmacol Exp Ther; 1988 Apr; 245(1):238-43. PubMed ID: 2834537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for delta receptor mediation of [D-Pen2,D-Pen5]-enkephalin (DPDPE) analgesia in mice.
    Heyman JS; Mosberg HI; Porreca F
    NIDA Res Monogr; 1986; 75():442-5. PubMed ID: 2828989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roles of mu, delta and kappa opioid receptors in spinal and supraspinal mediation of gastrointestinal transit effects and hot-plate analgesia in the mouse.
    Porreca F; Mosberg HI; Hurst R; Hruby VJ; Burks TF
    J Pharmacol Exp Ther; 1984 Aug; 230(2):341-8. PubMed ID: 6086883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of endogenous calcium and magnesium levels by delta opioid receptors in the rat brain.
    Gulya K; Kovács GL; Kása P
    Brain Res; 1991 Apr; 547(1):22-7. PubMed ID: 1650284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Supraspinal delta- and mu-opioid receptors mediate gastric mucosal protection in the rat.
    Gyires K; Rónai AZ
    J Pharmacol Exp Ther; 2001 Jun; 297(3):1010-5. PubMed ID: 11356923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sympathoadrenal, cardiovascular and blood gas responses to highly selective mu and delta opioid peptides.
    Kiritsy-Roy JA; Marson L; Van Loon GR
    J Pharmacol Exp Ther; 1989 Dec; 251(3):1096-103. PubMed ID: 2557411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The entry of [D-penicillamine2,5]enkephalin into the central nervous system: saturation kinetics and specificity.
    Thomas SA; Abbruscato TJ; Hruby VJ; Davis TP
    J Pharmacol Exp Ther; 1997 Mar; 280(3):1235-40. PubMed ID: 9067309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered disposition and antinociception of [D-penicillamine(2,5)] enkephalin in mdr1a-gene-deficient mice.
    Chen C; Pollack GM
    J Pharmacol Exp Ther; 1998 Nov; 287(2):545-52. PubMed ID: 9808679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of antinociception to opioid receptor selective agonists after antisense oligodeoxynucleotide-mediated "knock-down" of opioid receptor in vivo.
    Bilsky EJ; Bernstein RN; Hruby VJ; Rothman RB; Lai J; Porreca F
    J Pharmacol Exp Ther; 1996 Apr; 277(1):491-501. PubMed ID: 8613959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.